Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20251019004Phase 3Not yet recruiting
Phase 3, randomised trial in prostate disease (2 arms), sponsored by Lerdsin Hospital. Primary endpoint: Pain during TRUS-guided prostate biopsy. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20251019004.